[1] |
黄晓军 . 内科学-血液内科分册[M]. 北京: 人民卫生出版社, 2015: 136.
|
[2] |
Han C, Kwon B S . Chimeric antigen receptor T-cell therapy for cancer:a basic research-oriented perspective[J]. Immunotherapy, 2018,10(3):221-234.
|
[3] |
李萍, 梁爱斌 . 嵌合抗原受体T细胞在血液恶性肿瘤治疗中的临床应用[J]. 内科急危重症杂志, 2016,22(2):91-93.
|
[4] |
Lee L, Draper B, Chaplin N , et al. An APRIL-based chimeric antigen receptor for dual targeting of BCMA and TACI in multiple myeloma[J]. Blood, 2018,131(7):746-758.
|
[5] |
Hipp S, Tai YT, Blanset D , et al. A novel BCMA/CD3 bispecific T-cell engager for the treatment of multiple myeloma induces selectivelysis in vitro and in vivo[J]. Leukemia, 2017,31(10):2278.
|
[6] |
梅恒, 吴耀辉, 郭涛 , 等. CAR-T治疗细胞因子风暴中的出凝血异常、中枢神经系统改变[J]. 临床血液学杂志, 2016,29(4):557-559,562.
|
[7] |
Maus MV, Grupp SA, Porter DL , et al. Antibody-modified T- cells:CARs take the front seat for hematologic malignancies[J]. Blood, 2014,123(17):2625-2635.
|
[8] |
任巧玲 . 重型颅脑损伤并发神经原性肺水肿患者的护理[J]. 中华护理杂志, 2002,37(7):511-512.
|
[9] |
尤黎明, 吴瑛 . 内科护理学[M]. 北京: 人民卫生出版社, 2012: 189-191.
|
[10] |
舒平春 . 低血钾致尖端扭转型室性心动过速一例的抢救与护理[J]. 解放军护理杂志, 2011,28(7):57-59.
|
[11] |
Lee DW, Gardner R, Porter DL , et al. Current concepts in the diagnosis and management of cytokine release syndrome[J]. Blood, 2014,124(2):188-195.
|
[12] |
库洪安, 赵玉香, 赵丽 . 显性出汗量的计算[J]. 实用护理杂志, 2003,19(1):41.
|
[13] |
李丽娜, 万滢 . 嵌合抗原受体修饰T细胞免疫疗法治疗B细胞恶性肿瘤患者的护理[J]. 中华护理杂志, 2017,52(3):297-299.
|
[14] |
李清杰 . 医院感染防控指南[M]. 北京: 人民军医出版社, 2010: 441-444
|
[15] |
Neelapu SS, Tummala S, Kebriaei P , et al. Chimeric antigen receptor T-cell therapy-assessment and management of toxicities[J]. Nat Rev Clin Oncol, 2018,15(1):47-62.
|
[16] |
Lee DW, Kochenderfer JN, Stetler-Stevenson M , et al. T-cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults:a phase 1 dose-escalation trial[J]. Lancet, 2015,385(9967):517-528.
|
[17] |
Neelapu SS, Locke FL, Bartlett NL , et al. Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma[J]. N Engl J Med, 2017,377(26):2531-2544.
|